There were 1,576 press releases posted in the last 24 hours and 333,741 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GSK receives further data from phase lll studies of albiglutide in type 2 diabetes

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image